On 2025-11-13, Reviva Pharmaceuticals Holdings, Inc. (RVPH) announced earnings per share of $-1.20 for the fiscal quarter ending 2025-09-30, beating the average analyst estimate of $-2.20.
The next expected annoucement date for quarterly earnings is 2026-05-21, with an average estimated earnings per share of $-0.75 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-11-13 | 2025-09-30 | $-2.20 | $-1.20 |
| 2025-08-14 | 2025-06-30 | $-3.00 | $-2.40 |
| 2025-05-15 | 2025-03-31 | $-4.20 | $-2.60 |
| 2025-03-31 | 2024-12-31 | $-4.40 | $-3.00 |
| 2024-11-14 | 2024-09-30 | $-4.60 | $-5.00 |
| 2024-08-14 | 2024-06-30 | $-5.60 | $-5.20 |
| 2024-05-14 | 2024-03-31 | $-5.60 | $-5.00 |
| 2024-04-15 | 2023-12-31 | -- | $-7.00 |
| 2023-11-14 | 2023-09-30 | $-7.00 | $-8.80 |
| 2023-08-14 | 2023-06-30 | $-5.80 | $-11.00 |
| 2023-05-15 | 2023-03-31 | $-7.20 | $-6.00 |
| 2023-03-30 | 2022-12-31 | $-4.60 | $-7.60 |
| 2022-11-14 | 2022-09-30 | $-6.00 | $-3.60 |
| 2022-08-15 | 2022-06-30 | $-6.20 | $-5.80 |
| 2022-05-16 | 2022-03-31 | $-5.60 | $-8.00 |
| 2022-03-15 | 2021-12-31 | $-4.80 | $-4.80 |
| 2021-11-15 | 2021-09-30 | $-5.00 | $-2.40 |
| 2021-08-16 | 2021-06-30 | $-4.80 | $-2.40 |
| 2021-05-17 | 2021-03-31 | -- | $-2.00 |
| 2021-03-22 | 2020-12-31 | -- | $-16.80 |
| 2021-01-14 | 2020-11-30 | -- | $-2.60 |
| 2020-10-14 | 2020-08-31 | -- | $-3.80 |
| 2020-07-07 | 2020-05-31 | -- | $-1.80 |
| 2020-05-04 | 2020-02-29 | -- | $-2.60 |
| 2020-01-10 | 2019-11-30 | -- | $-1.00 |
| 2019-10-08 | 2019-08-31 | -- | $-0.40 |
| 2019-07-03 | 2019-05-31 | -- | $-0.20 |